The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
KRX Aesthetics PD-13 Therapy
KRX Aesthetics PD-13 Therapy · METHYL AMINOLEVULINATE HYDROCHLORIDE 1.95 mg/15mL · Spray · Topical · By Kin Aesthetics Llc
NDC 87565-0010-01 · 15 mL in 1 PACKAGE · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of KRX Aesthetics PD-13 Therapy (Spray)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| By Kin Aesthetics Llc | METHYL AMINOLEVULINATE HYDROCHLORIDE 1.95 mg/15mL | Jul 15, 2026 | Sep 2, 2026 |
| Krx Resources Sdn. Bhd. | METHYL AMINOLEVULINATE HYDROCHLORIDE 1.95 mg/15mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "KRX Aesthetics PD-13 Therapy — NDC 87565-0010-01," retrieved September 3, 2026, https://drugdashboards.com/drug/87565001001.
Free to cite with attribution — see how the data is put together.